1GSK purchased 340,000 ordinary shares on March 30, 2026, at a volume-weighted average price of 2,060.19p per share.
2The purchase was executed through BNP Paribas SA as part of the company's existing buyback programme announced on February 17, 2026.
3Following this purchase, GSK holds 255,772,615 ordinary shares in treasury and has 4,060,407,166 ordinary shares in issue (excluding treasury shares).
4The total number of voting rights in the company is 4,060,407,166, with treasury shares representing 6.30% of voting rights.
5Since February 17, 2026, the company has purchased a total of 15,881,521 ordinary shares under the buyback programme.